• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险模型在未来肺癌筛查试验中的应用潜力。

The potential for using risk models in future lung cancer screening trials.

作者信息

Field John K, Raji Olaide Y

机构信息

Roy Castle Lung Cancer Research Programme, School of Cancer Studies, University of Liverpool Cancer Research Centre 200 London Road, Liverpool, L3 9TA UK.

出版信息

F1000 Med Rep. 2010 May 24;2:38. doi: 10.3410/M2-38.

DOI:10.3410/M2-38
PMID:20948847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2950056/
Abstract

Computed tomography screening for early diagnosis of lung cancer is one of the more potentially useful strategies, aside from smoking cessation programmes, for reducing mortality and improving the current poor survival from this disease. The long-term success of lung cancer screening will be dependent upon identifying populations at sufficient risk in order to maximise the benefit-to-harm ratio of the intervention. Risk prediction models could potentially play a major role in the selection of high-risk individuals who would benefit most from screening intervention programmes for the early detection of lung cancer. Improvements of developed lung cancer risk prediction models (through incorporation of objective clinical factors and genetic and molecular biomarkers for precise and accurate estimation of risks), demonstration of their clinical usefulness in decision making, and their use in future screening programmes are the focus of current research.

摘要

除戒烟计划外,计算机断层扫描筛查用于肺癌的早期诊断是更具潜在实用价值的策略之一,有助于降低死亡率并改善目前该疾病较差的生存率。肺癌筛查的长期成功将取决于识别出足够高危的人群,以最大化干预措施的利弊比。风险预测模型在选择能从肺癌早期检测筛查干预计划中获益最大的高危个体方面可能发挥重要作用。改进已有的肺癌风险预测模型(通过纳入客观临床因素以及基因和分子生物标志物以精确准确地估计风险)、证明其在决策中的临床实用性以及将其应用于未来的筛查计划是当前研究的重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd83/2950056/3b5ebc3b5788/1757-5931-0002-0000000038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd83/2950056/3b5ebc3b5788/1757-5931-0002-0000000038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd83/2950056/3b5ebc3b5788/1757-5931-0002-0000000038-g001.jpg

相似文献

1
The potential for using risk models in future lung cancer screening trials.风险模型在未来肺癌筛查试验中的应用潜力。
F1000 Med Rep. 2010 May 24;2:38. doi: 10.3410/M2-38.
2
Lung cancer screening: identifying the high risk cohort.肺癌筛查:识别高危人群。
J Thorac Dis. 2015 Apr;7(Suppl 2):S156-62. doi: 10.3978/j.issn.2072-1439.2015.04.19.
3
The contribution of risk prediction models to early detection of lung cancer.风险预测模型在肺癌早期检测中的作用。
J Surg Oncol. 2013 Oct;108(5):304-11. doi: 10.1002/jso.23384. Epub 2013 Aug 29.
4
Lung cancer screening implementation: Complexities and priorities.肺癌筛查实施:复杂性与优先事项。
Respirology. 2020 Nov;25 Suppl 2:5-23. doi: 10.1111/resp.13963.
5
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.用于选择肺癌筛查候选者的风险预测模型:一项回顾性验证研究。
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
6
Application of risk prediction models to lung cancer screening: a review.风险预测模型在肺癌筛查中的应用:综述
J Thorac Imaging. 2015 Mar;30(2):88-100. doi: 10.1097/RTI.0000000000000142.
7
Early detection in lung cancer. Case finding and screening.肺癌的早期检测。病例发现与筛查。
Med Clin North Am. 1996 Jan;80(1):63-82. doi: 10.1016/s0025-7125(05)70427-2.
8
9
10
The Future of Lung Cancer Screening: Current Challenges and Research Priorities.肺癌筛查的未来:当前挑战与研究重点
Cancer Manag Res. 2022 Feb 16;14:637-645. doi: 10.2147/CMAR.S293877. eCollection 2022.

引用本文的文献

1
Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma.结合基因突变和表达谱可鉴定肺腺癌新的预后生物标志物。
Clin Med Insights Oncol. 2020 Oct 28;14:1179554920966260. doi: 10.1177/1179554920966260. eCollection 2020.
2
A novel CpG-based signature for survival prediction of lung adenocarcinoma patients.一种用于预测肺腺癌患者生存的基于CpG的新型标志物。
Exp Ther Med. 2020 Jan;19(1):280-286. doi: 10.3892/etm.2019.8200. Epub 2019 Nov 15.
3
Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review.

本文引用的文献

1
General practitioner or computerised algorithm?全科医生还是计算机算法?
Lancet. 2010 Jan 9;375(9709):94. doi: 10.1016/S0140-6736(10)60031-1.
2
The National Awareness and Early Diagnosis Initiative in England: assembling the evidence.英格兰国家意识和早期诊断计划:汇集证据。
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S1-4. doi: 10.1038/sj.bjc.6605382.
3
Management of lung nodules detected by volume CT scanning.容积CT扫描检测出的肺结节的管理
自身抗体作为肺癌诊断生物标志物的系统评价。
Cell Death Discov. 2019 Aug 5;5:126. doi: 10.1038/s41420-019-0207-1. eCollection 2019.
4
Large-scale gene expression analysis reveals robust gene signatures for prognosis prediction in lung adenocarcinoma.大规模基因表达分析揭示了用于肺腺癌预后预测的强大基因特征。
PeerJ. 2019 Jun 3;7:e6980. doi: 10.7717/peerj.6980. eCollection 2019.
5
Circulating microRNA biomarkers for lung cancer detection in Western populations.用于西方人群肺癌检测的循环 microRNA 生物标志物。
Cancer Med. 2018 Oct;7(10):4849-4862. doi: 10.1002/cam4.1782. Epub 2018 Sep 27.
6
Twenty-gene-based prognostic model predicts lung adenocarcinoma survival.基于20个基因的预后模型预测肺腺癌生存率。
Onco Targets Ther. 2018 Jun 12;11:3415-3424. doi: 10.2147/OTT.S158638. eCollection 2018.
7
Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm.在初级保健中识别疑似肺癌患者:算法的推导和验证。
Br J Gen Pract. 2011 Nov;61(592):e715-23. doi: 10.3399/bjgp11X606627.
N Engl J Med. 2009 Dec 3;361(23):2221-9. doi: 10.1056/NEJMoa0906085.
4
Putting risk prediction in perspective: relative utility curves.正确看待风险预测:相对效用曲线。
J Natl Cancer Inst. 2009 Nov 18;101(22):1538-42. doi: 10.1093/jnci/djp353. Epub 2009 Oct 20.
5
Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer.肺癌风险模型在肺癌CT筛查研究及服务项目规划中的应用。
Expert Rev Anticancer Ther. 2009 Oct;9(10):1467-72. doi: 10.1586/era.09.87.
6
Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.既往肺结核与肺癌风险关系的事实与虚构:一项系统综述
Int J Cancer. 2009 Dec 15;125(12):2936-44. doi: 10.1002/ijc.24636.
7
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.肺癌与慢性阻塞性肺疾病:综合研究的需求与机遇
J Natl Cancer Inst. 2009 Apr 15;101(8):554-9. doi: 10.1093/jnci/djp023. Epub 2009 Apr 7.
8
An expanded risk prediction model for lung cancer.一种用于肺癌的扩展风险预测模型。
Cancer Prev Res (Phila). 2008 Sep;1(4):250-4. doi: 10.1158/1940-6207.CAPR-08-0060.
9
Lung cancer risk models come of age.肺癌风险模型已成熟。
Cancer Prev Res (Phila). 2008 Sep;1(4):226-8. doi: 10.1158/1940-6207.CAPR-08-0144.
10
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.决策曲线分析的扩展,一种评估诊断试验、预测模型和分子标志物的新方法。
BMC Med Inform Decis Mak. 2008 Nov 26;8:53. doi: 10.1186/1472-6947-8-53.